Biomarker Technologies Compares DNA Sequencing Methods for Microbiome Studies
Biomarker Technologies (BMKGene) has released a comparative analysis of amplicon and shotgun metagenomic sequencing for microbiome research. The study details the strengths and limitations of each method to aid researchers in selecting the appropriate approach.

Biomarker Technologies (BMKGene) has published a comprehensive comparison of two primary DNA sequencing methods used in microbiome research: amplicon sequencing and shotgun metagenomic sequencing. The analysis aims to provide researchers with a clear understanding of the distinct characteristics of each technique to facilitate informed method selection.
Aplicon sequencing targets specific marker genes, such as 16S rRNA, providing insights into the taxonomic composition and diversity of microbial communities. This method is often favored for its cost-effectiveness with large sample numbers and its ability to yield results even with degraded DNA or low biomass samples. However, it typically offers genus-level resolution and can be subject to primer bias.
In contrast, shotgun metagenomic sequencing fragments total community DNA and sequences it randomly. This approach yields a broader picture, capturing genomic information, functional genes, and even viruses. It allows for species and strain-level resolution and direct functional gene recovery, but requires higher quality DNA and significant computational resources for analysis.
BMKGene highlights that the choice between these methods depends critically on the research objectives. Shotgun metagenomics is better suited for studies investigating strain variation, metabolic pathways, or discovering novel organisms. Amplicon sequencing remains valuable for large-scale diversity screening and projects with budget constraints.
The company offers both amplicon and shotgun metagenomic sequencing services, along with experimental design and bioinformatic analysis, to support a range of microbiome research needs.